TAZ inhibition promotes IL-2-induced apoptosis of hepatocellular carcinoma cells by activating the JNK/F-actin/mitochondrial fission pathway
Cytokine-based cancer therapies have attracted a great deal of attention in recent years. Unfortunately, resistance to treatment limits the efficacy of these therapeutics. Therefore, the aim of our study was t...
Source: Cancer Cell International - Category: Cancer & Oncology Authors: Kaihua Ji, Kaili Lin, Yan Wang, Liqing Du, Chang Xu, Ningning He, Jinhan Wang, Yang Liu and Qiang Liu Tags: Primary research Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Study